Bank of New York Mellon Corp - ORTHOPEDIATRICS CORP ownership

ORTHOPEDIATRICS CORP's ticker is KIDS and the CUSIP is 68752L100. A total of 130 filers reported holding ORTHOPEDIATRICS CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ORTHOPEDIATRICS CORP
ValueSharesWeighting
Q3 2023$1,783,040
-29.1%
55,720
-2.9%
0.00%
-100.0%
Q2 2023$2,516,244
+1.6%
57,383
+2.6%
0.00%0.0%
Q1 2023$2,476,563
+9.7%
55,917
-1.6%
0.00%0.0%
Q4 2022$2,256,625
-9.8%
56,799
+4.7%
0.00%0.0%
Q3 2022$2,501,000
+18.9%
54,225
+11.2%
0.00%
Q2 2022$2,104,000
-24.2%
48,750
-5.1%
0.00%
-100.0%
Q1 2022$2,774,000
-9.6%
51,375
+0.3%
0.00%0.0%
Q4 2021$3,067,000
-10.5%
51,246
-2.0%
0.00%0.0%
Q3 2021$3,426,000
+14.1%
52,299
+10.0%
0.00%0.0%
Q2 2021$3,003,000
+10.4%
47,530
-14.8%
0.00%0.0%
Q1 2021$2,719,000
+11.7%
55,795
-5.5%
0.00%0.0%
Q4 2020$2,435,000
-7.0%
59,015
+3.5%
0.00%0.0%
Q3 2020$2,619,000
+17.1%
57,045
+11.6%
0.00%0.0%
Q2 2020$2,237,000
+29.2%
51,132
+16.9%
0.00%0.0%
Q1 2020$1,732,000
+0.9%
43,723
+19.8%
0.00%
Q4 2019$1,716,000
+53.5%
36,511
+15.2%
0.00%
Q3 2019$1,118,000
-11.3%
31,694
-1.9%
0.00%
Q2 2019$1,261,000
+22.4%
32,324
+38.9%
0.00%
Q1 2019$1,030,000
+37.3%
23,270
+8.2%
0.00%
Q4 2018$750,000
+8.9%
21,500
+14.3%
0.00%
Q3 2018$689,000
+41.2%
18,803
+2.7%
0.00%
Q2 2018$488,00018,3130.00%
Other shareholders
ORTHOPEDIATRICS CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Endurant Capital Management LP 70,364$2,251,6482.02%
NEXT CENTURY GROWTH INVESTORS LLC 563,602$18,035,2641.96%
AWM Investment Company, Inc. 377,276$12,072,8321.78%
Brown Capital Management 3,503,939$112,126,0481.72%
FORMULA GROWTH LTD 124,970$3,999,0401.36%
BRAIDWELL LP 1,057,770$33,848,6401.07%
First Light Asset Management, LLC 305,238$9,767,6160.93%
Granahan Investment Management 591,605$18,931,3600.67%
RIVERBRIDGE PARTNERS LLC 950,590$30,418,8820.44%
Intrinsic Edge Capital Management LLC 50,000$1,600,0000.18%
View complete list of ORTHOPEDIATRICS CORP shareholders